Keith Russell

Title: Keith Russell - A Trailblazer in Pharmaceutical Innovations

Introduction

Keith Russell, an esteemed inventor based in Newark, DE, has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 20 patents. His expertise lies in developing novel compounds aimed at treating various medical conditions, particularly asthma.

Latest Patents

Among his most recent innovations are two notable patents that focus on Azospiro compounds and Piperidinyl compounds, both of which serve as NK1 or NK2 antagonists. The compounds detailed in these patents are nonpeptide antagonists of substance P (SP) and neurokinin A (NKA), showcasing promise in the treatment of asthma. These patents not only include the compounds of formula I but also elaborate on their N-oxides and pharmaceutically acceptable salts, alongside pharmaceutical compositions and processes for preparing the compounds.

Career Highlights

Keith Russell's career has been marked by his tenure at prestigious companies including Zeneca Limited and Imperial Chemical Industries Limited, where he has honed his skills and expanded his knowledge in pharmaceutical research and development.

Collaborations

Throughout his career, Keith has collaborated with notable professionals in the field such as Cyrus J Ohnmacht and Keith H Gibson. These partnerships have facilitated the advancement of his innovative ideas and have contributed to the successful development of his patents.

Conclusion

With a robust portfolio and a commitment to improving health through medicine, Keith Russell stands out as a prominent figure in pharmaceutical innovations. His work continues to impact the treatment of asthma and demonstrates the vital role of inventors in advancing medical science.